Social and Economic Challenges to Implementing the Ketogenic Diet: A Case Series

Abstract

The ketogenic diet (KD) is a powerful therapeutic tool that can reduce seizure activity in patients with refractory epilepsy. However, dietary implementation can be difficult for patients and families due to the time and resource intensive nature of the diet. These challenges are particularly pronounced in economically disadvantaged or socially unstable patient populations. The first case of this series describes the successful implementation of KD in a low-income, homeless patient through the use of innovative KD recipes and access to social programs offered through Boston Medical Center. The second case illustrates the importance of consistent parental support to the success of KD and describes mechanisms used to improve familial support within a nonunified household. Collectively, these cases demonstrate ways by which health care providers can make this powerful dietary treatment accessible to low-resource patients.

Keywords

ketogenic diet - epilepsy - socioeconomic barriers

Publikationsverlauf

Eingereicht: 13. Februar 2020

Angenommen: 02. Juni 2020

Artikel online veröffentlicht:
15. Juli 2020

• References

• 1 Kossoff EH, Zupec-Kania BA, Rho JM. Ketogenic diets: an update for child neurologists. J Child Neurol 2009; 24 (08) 979-988
• 2 Klein P, Tyrlikova I, Mathews GC. Dietary treatment in adults with refractory epilepsy: a review. Neurology 2014; 83 (21) 1978-1985
• 3 Henderson CB, Filloux FM, Alder SC, Lyon JL, Caplin DA. Efficacy of the ketogenic diet as a treatment option for epilepsy: meta-analysis. J Child Neurol 2006; 21 (03) 193-198
• 4 Kossoff EH, Hartman AL. Ketogenic diets: new advances for metabolism-based therapies. Curr Opin Neurol 2012; 25 (02) 173-178
• 5 Hartman AL, Vining EPG. Clinical aspects of the ketogenic diet. Epilepsia 2007; 48 (01) 31-42
• 6 Weber S, Mølgaard C, Karentaudorf, Uldall P. Modified Atkins diet to children and adolescents with medical intractable epilepsy. Seizure 2009; 18 (04) 237-240
• 7 Lefevre F, Aronson N. Ketogenic diet for the treatment of refractory epilepsy in children: a systematic review of efficacy. Pediatrics 2000; 105 (04) E46
• 8 Kossoff EH, Zupec-Kania BA, Amark PE. et al; Charlie Foundation, Practice Committee of the Child Neurology Society, Practice Committee of the Child Neurology Society, International Ketogenic Diet Study Group. Optimal clinical management of children receiving the ketogenic diet: recommendations of the International Ketogenic Diet Study Group. Epilepsia 2009; 50 (02) 304-317
• 9 Paoli A. Ketogenic diet for obesity: friend or foe?. Int J Environ Res Public Health 2014; 11 (02) 2092-2107
• 10 Krebs HA. The regulation of the release of ketone bodies by the liver. Adv Enzyme Regul 1966; 4: 339-354
• 11 Liu Y-M, Wang H-S. Medium-chain triglyceride ketogenic diet, an effective treatment for drug-resistant epilepsy and a comparison with other ketogenic diets. Biomed J 2013; 36 (01) 9-15
• 12 Martin-McGill KJ, Jackson CF, Bresnahan R, Levy RG, Cooper PN. Ketogenic diets for drug-resistant epilepsy. Cochrane Database Syst Rev 2018; 11 (November): CD001903
• 13 Martin K, Jackson CF, Levy RG, Cooper PN. Ketogenic diet and other dietary treatments for epilepsy. Cochrane Database Syst Rev 2016; 2 (September): CD001903
• 14 Brietzke E, Mansur RB, Subramaniapillai M. et al. Ketogenic diet as a metabolic therapy for mood disorders: evidence and developments. Neurosci Biobehav Rev 2018; 94 (July): 11-16
• 15 Poelzer K, Mannion C, Ortiz MM, Bang R, Woods P. A systematic review of the quality of life for families supporting a child consuming the ketogenic diet for seizure reduction. Curr Dev Nutr 2018; 3 (05) nzz079
• 16 de Kinderen RJ, Lambrechts DAJE, Wijnen BFM. et al. An economic evaluation of the ketogenic diet versus care as usual in children and adolescents with intractable epilepsy: an interim analysis. Epilepsia 2016; 57 (01) 41-50
• 17 Martinez DM, Cramp L. The Keto Cookbook. New York, NY: Springer Publishing Company; 2011
• 18 Mady MA, Kossoff EH, McGregor AL, Wheless JW, Pyzik PL, Freeman JM. The ketogenic diet: adolescents can do it, too. Epilepsia 2003; 44 (06) 847-851
• 19 Kyngäs H. Compliance of adolescents with chronic disease. J Clin Nurs 2000; 9 (04) 549-556
• 20 Draper CE, Grobler L, Micklesfield LK, Norris SA. Impact of social norms and social support on diet, physical activity and sedentary behaviour of adolescents: a scoping review. Child Care Health Dev 2015; 41 (05) 654-667
• 21 Scaglioni S, Arrizza C, Vecchi F, Tedeschi S. Determinants of children's eating behavior. Am J Clin Nutr 2011; 94 (06) 2006S-2011S
• 22 van Delft R, Lambrechts D, Verschuure P, Hulsman J, Majoie M. Blood beta-hydroxybutyrate correlates better with seizure reduction due to ketogenic diet than do ketones in the urine. Seizure 2010; 19 (01) 36-39
• 23 Gilbert DL, Pyzik PL, Freeman JM. The ketogenic diet: seizure control correlates better with serum β-hydroxybutyrate than with urine ketones. J Child Neurol 2000; 15 (12) 787-790
• 24 Pehrsson PR, Haytowitz DB, McKillop KA. et al. USDA Branded Food Products Database. USDA Agricultural Research Service. 2018 . Accessed January 25, 2019 at: https://data.nal.usda.gov/dataset/usda-branded-food-products-database